Institutional research misconduct

BMJ 2011; 343 doi: (Published 9 November 2011)
Cite this as: BMJ 2011;343:d7284

Related articles

Feature: Managing research misconduct: is anyone getting it right?

Letter: Update from the editor

Letter: MMR is but the tip of the iceberg

Letter: BMJ is in danger of losing sight of the patient

Letter: Money is the greatest conflict of all

Feature: Pathology reports solve “new bowel disease” riddle

Feature: Commentary: I see no convincing evidence of “enterocolitis,” “colitis,” or a “unique disease process”

Feature: Commentary: We came to an overwhelming and uniform opinion that these reports do not show colitis

Editor's Choice: Welcome to the new design

Feature: The Lancet’s two days to bury bad news

Feature: How the case against the MMR vaccine was fixed

See more

Practice: Ordering and interpreting hepatitis B serology

News: Tamiflu purchase worth £49m will go ahead, government says

Clinical Review: Anticoagulation in atrial fibrillation

News: Cochrane review questions effectiveness of neuraminidase inhibitors

This article has been cited by other articles: